These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 64759)

  • 1. 1,25-dihydroxycholecalciferol from a plant.
    Lancet; 1977 Jan; 1(8005):233. PubMed ID: 64759
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 4. [Solanum malacoxylon as a therapeutic alternative for 1,25-dihydroxycholecalciferol in uraemic disorders of calcium metabolism (author's transl)].
    von Herrath D; Kraft D; Offermann G; Schaefer K
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2407-9. PubMed ID: 4426262
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
    Brickman AS; Coburn JW; Norman AW; Massry SG
    Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
    [No Abstract]   [Full Text] [Related]  

  • 6. 1,25-dihydroxycholecalciferol in hypophosphataemic osteomalacia presenting in adults.
    Offermann G; Delling G; Haussler MR
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):408-16. PubMed ID: 580838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcinogenic factor in Solanum malacoxylon: evidence that it is 1,25-dihydroxyvitamin D3-glycoside.
    Wasserman RH; Henion JD; Haussler MR; McCain TA
    Science; 1976 Nov; 194(4267):853-5. PubMed ID: 982048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absolute configuration of the natural 25,26-dihydroxycholecalciferol.
    Redel J; Bazely N; Tanaka Y; DeLuca HF
    FEBS Lett; 1978 Oct; 94(2):228-30. PubMed ID: 700144
    [No Abstract]   [Full Text] [Related]  

  • 10. 24,25-Dihydroxycholecalciferol treatment of osteomalacia: use in a patient with vitamin D deficiency and hyperparathyroidism.
    Silver J; Zimmerman J; Sela J; Rubinger D; Friedlaender MM; Popovtzer MM
    Isr J Med Sci; 1984 May; 20(5):437-9. PubMed ID: 6332095
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recommended for use in various bone diseases: therapy with a vitamin D metabolite].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1062. PubMed ID: 114759
    [No Abstract]   [Full Text] [Related]  

  • 12. 1, 25-dihydroxyvitamin D3-glycoside: identification of a calcinogenic principle of Solanium malocoxylon.
    Haussler MR; Wasserman RH; McCain TA; Peterlik M; Bursac KM; Hughes MR
    Life Sci; 1976 May; 18(10):1049-56. PubMed ID: 933696
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of vitamin D metabolites in humans.
    Rasmussen H; Bordier P; Marie P; Miravet L; Ryckwaert A
    Trans Assoc Am Physicians; 1977; 90():380-9. PubMed ID: 611668
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of dialysis osteomalacia despite treatment with 24R,25-dihydroxycholecalciferol.
    Phelps KR; Einhorn TA; Vigorita VJ; Jones G; Lundin AP
    Nephron; 1989; 51(2):197-206. PubMed ID: 2783766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolites: extraction from tissue and partial purification prior to chromatography.
    Ross FP; Norman AW
    Methods Enzymol; 1980; 67():426-30. PubMed ID: 7366443
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D3 receptors in cancer.
    Manolagas SC; Haussler MR; Deftos LJ
    Lancet; 1980 Apr; 1(8172):828. PubMed ID: 6102717
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W; Spiegel P; Gessler U; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 1 alpha,25-dihydroxycholecalciferol on disuse osteoporosis in the dog: a histomorphometric study.
    Caywood DD; Wallace LJ; Olson WG; Stevens JB
    Am J Vet Res; 1979 Jan; 40(1):89-91. PubMed ID: 453689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.